Oct 05, 2021
Mauna Kea Technologies Announces 5 Communications Highlighting the Clinical Value of Cellvizio® in Interventional Pulmonology Presented During the European Respiratory Society (ERS) International Congress 2021
Oct 04, 2021
Virica Biotech Raises Series A Financing and Expands Operations to Support Clients’ Manufacturing of Viral Medicines
Sep 22, 2021
SHINE’s new name highlights technology competencies and multiple phase opportunities
Sep 22, 2021
Humanetics Corporation Announces Results from Phase 1 Trial of BIO 300 Oral Powder
Sep 17, 2021
Global $5.848 Billion Radiotherapy Devices Market 2021: COVID-19 Growth and Change to 2030 - ResearchAndMarkets.com
Sep 14, 2021
The Engine Appoints MIT Institute Professor Paula Hammond to Its Board of Directors
Sep 14, 2021
Tachyum and Slovak University of Technology Sign Memorandum of Understanding for Collaboration
Sep 08, 2021
Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine
Aug 24, 2021
Humanetics Corporation’s BIO 300 Receives Fast Track Designation from FDA
Jul 29, 2021
Introducing Landmark Bio™ and Appointment of Ran Zheng as CEO
Jul 28, 2021
Bluebird Bio and Resilience Announce Strategic Alliance to Develop Next Generation Cell Therapies
Jul 16, 2021
GC LabCell and GC Cell to Merge, Creating a Premier Cell Therapy Company
Jul 14, 2021
NEC’s Artificial Intelligence (AI) Supports Doctors to Determine If Colorectal Lesions Are Potentially Neoplastic
Jun 19, 2021
Cancer Diagnostics, Inc. Acquires Anatech, Ltd.
Jun 09, 2021
SHINE Medical announces irradiation agreement with MURR, will exhibit at SNMMI 2021 Virtual Annual Meeting
Jun 07, 2021
Gamida Cell Announces Appointment of Senior Vice President, Global Operations and Manufacturing and Provides Commercial Manufacturing Update
Jun 03, 2021
Personalis Announces Delivery of the 125,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program
Jun 03, 2021
A Toxic Legacy Bubbling Below: Webinar to Convene Scientists from Across California to Discuss DDT’s Deadly Effects
Jun 02, 2021
Sesen Bio Announces Global Supply Partnership with Qilu Pharmaceutical
Jun 02, 2021
Harvard Licenses Technology to Obatala Sciences to Advance Discovery in Obesity, Diabetes, and Cancer